Stay in Touch
To keep in touch, please sign up to the Milltrust Ventures Newsletter for our latest news and insights.
On the bravest frontier in human health, scientists are using bacteria from the digestive system to create novel medicines for a huge range of ailments including Parkinson’s, cancer and autism. The results could transform lives and deliver massive returns for early investors
Milltrust’s VC partner Cerracap was a day 1 investor into Viome. We are proud to have helped pioneered this fascinating technology which uses AI to analyse millions of data points derived from the contents of our gut.
Tags: Cerracap Healthcare Science Technology viome